Testing version — LOERadar is in active testing. Features and data may change.
TOPOTECAN (TOPOTECAN HYDROCHLORIDE) | LOERadar
TOPOTECAN
NDA
TOPOTECAN HYDROCHLORIDE | N200199 | SANDOZ INC
3 strengths0 unique patents0 unique exclusivities
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
No ANDA patent litigation cases (NOS 835) matched from PACER
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (3)
Sort:
#001 — EQ 1MG BASE/ML (EQ 1MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
RLD
0 patents0 exclusivities▴
SOLUTION;INTRAVENOUS | Approved: Feb 25, 2011
No patent or exclusivity listings for this strength.
#002 — EQ 3MG BASE/3ML (EQ 1MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
RLD
0 patents0 exclusivities▾
SOLUTION;INTRAVENOUS | Approved: Feb 25, 2011
#003 — EQ 4MG BASE/4ML (EQ 1MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**